Share options Company may be made available for issue under any discretionary share scheme in any The Group operates three share option schemes.
Details of options held by directors other 10 year period.
In addition, the rules contain a 3 per cent in 3 year limit, under which no than under savings related share option schemes are given below.
The executive directors more than 3 per cent of the issued share capital may be made available for issue under are responsible for supervising the share option schemes in accordance with rules approved 1 discretionary options in any 3 year period.
Whilst the 7 2 per cent limit is considered by shareholders in general meeting.
Under the provisions of the executive share option appropriate given the relatively limited number of shares issued over recent years to finance schemes, directors, managers and employees who are judged to have made a significant the growth of the business and the increased need to offer share options to retain key contribution to the Groups development to date, and are considered to be likely to continue employees in all the Groups geographic markets, the 3 per cent limit, which is no longer a to provide an exceptional and continuing contribution to the realisation of strategic goals in requirement of the Association of British Insurers, is felt unduly restrictive and, therefore, it the future, are granted share options in the Company.
On 16 December 1999 a new is proposed to seek shareholder approval to the removal of this limitation at the Annual executive share option scheme was approved by shareholders.
2 All share options exercised above were exercised on 3 May 2002 when the prevailing market price was 194.15p.
3 Total gains on the exercise of share options were 692,324 2001: 1,182,061, including 690,460 2001: 1,109,400 on executive share options.
4 Including gains on share options, the total emoluments of the highest paid director were 1,138,046 2001: 1,571,030.
1 Overview 2 Chairmans and Chief Executives Review 16 Directors and Advisers 18 Financial Review 20 Directors Report 23 Corporate Governance Statement 26 Remuneration and Succession Committee Report 29 Independent Auditors Report 30 Consolidated Profit and Loss Account 31 Consolidated Balance Sheet 32 Company Balance Sheet 33 Consolidated Cash Flow Statement 34 Consolidated Statement of Total Recognised Gains and Losses p 26 34 Reconciliation of Movements in Equity Shareholders Funds 35 Notes to the Accounts 56 Notice of Meeting 57 Financial Calendar p 27
